UHS Price Prediction Next Week
Technical Analysis: UHS shows a bullish trend in recent trading sessions, with the stock closing at $163.63 on Friday. The price has formed higher lows and higher highs, indicating positive momentum.
News Impact: UHS is scheduled to report Q4 2024 earnings on February 26. Market expectations are for earnings of $4.18 per share, representing a 33.6% year-over-year increase, with revenues projected at $3.99 billion, up 7.9% from the previous year.
Price Prediction for Next Week (Feb 25-Mar 1): Based on technical indicators and upcoming earnings catalyst:
- Support levels: $162.10, $160.03
- Resistance levels: $165.66, $168.00
- Target price range: $165-170
Trading Recommendation: BUY
- Entry point: Current market price ($163.63)
- Short-term target: $168.00 (post-earnings)
- Stop loss: $160.00
Rationale:
- Strong upward momentum in price action
- Positive earnings expectations
- Healthcare sector showing resilience as new market leader
- Volume increase on up days suggests institutional buying interest
The stock is likely to see increased volatility around earnings announcement, but positive sector sentiment and strong earnings expectations support an upward bias.
UHS Similar Chart Price Prediction
The price of UHS is predicted to go up -0.74%, based on the high correlation periods with XNET. The similarity of these two price pattern on the periods is 91.83%.
UHS
XNET
Down: -0.74%Similarity: 91.83%
UHS Revenue Forecast
UHS EPS Forecast
UHS FAQs
What is bull’s view on UHS?
What is bear's view on UHS?
What is UHS revenue forecast for next quarter？
What is UHS eps forecast for next quarter？
UHS Analyst's Forecast
Benjamin Rossi
JP Morgan
Hold
2024-12-17
Price Target
$226
Upside
+23.77%
JPMorgan assumed coverage of Universal Health with a Neutral rating and $226 price target. The firm believes favorable trends across sales and expenses for managed care companies should allow for margin expansion in 2025, but considers the setup into 2026 to be more bearish, saying potential volume rollover and regulatory uncertainty following the November elections present an "imperfect storm" of payer mix headwinds and a negative overhang on go-forward sentiment for the hospitals.
Ryan Langston
TD Cowen
Strong Buy
2024-11-26
Price Target
$275 → $251
Upside
+21.79%
Stephen Baxter
Wells Fargo
Buy
2024-11-25
Price Target
$285 → $230
Upside
+15.46%
